Interstitial laser coagulation in the management of lower urinary tract symptoms suggestive of bladder outlet obstruction from benign prostatic hyperplasia: long‐term follow‐up

Daehlin, L.; Frugård, Jannicke

doi:10.1111/j.1464-410x.2007.06863.x

Cited by 11 publications

(14 citation statements)

References 22 publications

(26 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In addition, several studies have indicated that ILC often has effects on voiding variables and a high retreatment rate [11] . Laguna et al [24] reported that the retreatment rate was 15% in the first year following ILC, and further increased to about 40% 3 years after surgery, which was consistent with the study of Liedberg et al [29] .…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Combination of Channel-TURP and ILC versus Standard TURP or ILC for Elderly with Benign Prostatic Hyperplasia: A Randomized Prospective Trial

Zhang

Wu²,

Chen³

et al. 2011

Urol Int

View full text Add to dashboard Cite

Purpose: A prospective randomized controlled trial was performed in elderly patients with benign prostatic hyperplasia (BPH) to evaluate the clinical effectiveness of channel transurethral resection of the prostate (C-TURP) combined with an interstitial laser coagulation (ILC) technique during a 4-year follow-up period. Methods: A total of 150 consecutive BPH patients were randomized to an ILC+C-TURP group (n = 50), an ILC group (n = 50) and a TURP group (n = 50). Urinary tract infection, acute urinary retention and retrograde ejaculation were monitored, and the retreatment rate, international prostate symptom score (IPSS) and maximum flow rate (Q_max) were measured. Results: A total of 142 patients completed the follow-up and were recruited for further analysis. At 1 month, the proportion of patients with urinary tract infection was similar between the C-TURP+ILC group and the TURP group (8.5 and 6.5%, p > 0.05), but significantly higher than that in the ILC group (51%, p < 0.001). Acute urinary retention was found in 30.6% of patients in the ILC group, but was not observed in the C-TURP+ILC and TURP groups. In the TURP group, the rate of retrograde ejaculation was significantly higher than that in the other 2 groups (p < 0.001). The retreatment rate was 8.5, 36.7 and 2.2% in the C-TURP+ILC, ILC and TURP groups, respectively (p < 0.001). When compared with baseline, the IPSS in the C-TURP+ILC, ILC and TURP groups was decreased by 70.6, 45.4, and 81.0%, respectively (ILC vs. C-TURP+ILC or TURP, p < 0.01) at the 48-month follow-up. One month after surgery, the Q_max was significantly increased in the C-TURP+ILC group and the TURP group when compared with that at baseline (p < 0.01). The TURP group had the highest and the ILC group had the lowest increase in the Q_max at the 12-, 24-, and 48-month follow-ups (p < 0.05). Conclusions: C-TURP+ILC is a safe and effective modality for the treatment of BPH, and exhibits favorable short-term clinical response and long-term durability. It is relatively reasonable and acceptable for treatment of high-risk elderly patients or those with a limited life expectancy.

show abstract

Section: Discussionmentioning

confidence: 99%

“…It is also a minimally invasive technique requiring regular TURP equipments and can relieve lower urinary tract obstruction and recover urinary function [11][12][13] .…”

Section: Introductionmentioning

confidence: 99%

Combination of Channel-TURP and ILC versus Standard TURP or ILC for Elderly with Benign Prostatic Hyperplasia: A Randomized Prospective Trial

Zhang

Wu²,

Chen³

et al. 2011

Urol Int

View full text Add to dashboard Cite

show abstract

“…Mean IPSS in our analysis decreased from 20 to 11.3 points and mean Qmax increased from 8.5 to 11.1 ml/sec during long term follow-up. Daehlin et al [9] reported a decrease of median IPSS from 22 to 13 points and an increase of Qmax from 8.6 to 10.2 ml/sec. Our patient cohort contains 37 patients who had a transurethral catheter preoperatively.…”

Section: Discussionmentioning

confidence: 99%

“…Taken into consideration the modest results of ILC presented in our analysis it seems difficult to support further use of this technique except in very selected patient groups [9,14]. Table 2: Cox proportional hazards analysis of predictive factors for treatment failure.…”

Section: Discussionmentioning

confidence: 99%

Long-Term Results of Interstitial Laser Coagulation for the Treatment of Benign Prostatic Obstruction

Zastrow

Oehlschlaeger²,

Froehner³

et al. 2014

Med Surg Urol

View full text Add to dashboard Cite

Objectives: Long term data on the outcome of interstitial laser coagulation for the treatment of sub vesical obstruction due to benign prostatic enlargement have been rarely published. Our long-term outcome data are presented and the technique of interstitial laser coagulation is critically evaluated. Methods:We carried out an evaluation of the outcome of consecutive interstitial laser coagulation procedures between 1999 and 2004. Follow-up was done by questionnaires sent to the outpatient urologists and by telephone interviews of patients.Results: 68 patients were treated with ILC. Follow up was available for 66 patients (97%). Mean follow up was 41 months, 40 of 66 patients have been voiding spontaneously after ILC treatment (61%). Mean residual urine volume of these patients at the time of follow up was 25 ml (0-120 ml). Mean Qmax at the time of follow-up was 11.1 ± 4.5 ml/sec. 16 patients have needed a secondary procedure for bladder outlet obstruction (TURP in most of these) and have been catheter-free since that. 10 patients remained on catheter drainage. A history of high residual urine volume or urinary retention was identified as predictor for treatment failure. Conclusion:Interstitial laser coagulation can be used in selected patients with multiple comorbidities for the treatment of benign prostatic hyperplasia.

show abstract

“…Several authors have concluded that this modality should probably be restricted to selected, high-risk patients. It can be safely performed with a combination of local anesthesia and intravenous sedation [Daehlin and Frugârd, 2007].…”

Section: Laser Applications In Urologymentioning

confidence: 99%

The evolution of lasers in urology

Zarrabi

Gross

2011

Therapeutic Advances in Urology

View full text Add to dashboard Cite

The world's first laser was developed by Theodore Maiman in 1960. Over the course of the past five decades, this technology has evolved into a highly specialized entity, also finding a niche market in the field of urology. Lasers obtained from various lasing mediums producing amplified light of different wavelengths have been tested for urological applications. Today, these lasers are most commonly used in the surgical management of benign prostatic hyperplasia and as intracorporeal lithotripters. Other uses include ablation of various urologic tumors and incising strictures of the upper-and lower urinary tract. A continuous process of evolution of this technology is taking place, resulting in surgical lasers becoming ever safer, more effective, and more affordable.

show abstract

Interstitial laser coagulation in the management of lower urinary tract symptoms suggestive of bladder outlet obstruction from benign prostatic hyperplasia: long‐term follow‐up

Cited by 11 publications

References 22 publications

Combination of Channel-TURP and ILC versus Standard TURP or ILC for Elderly with Benign Prostatic Hyperplasia: A Randomized Prospective Trial

Combination of Channel-TURP and ILC versus Standard TURP or ILC for Elderly with Benign Prostatic Hyperplasia: A Randomized Prospective Trial

Long-Term Results of Interstitial Laser Coagulation for the Treatment of Benign Prostatic Obstruction

The evolution of lasers in urology

Contact Info

Product

Resources

About